Skip to content
DiseaseQ3500973· pop 8· linked from 27 articles

لیپوآتروفی

Sign in to save

Lipoatrophy is the term describing the localized loss of fat tissue. This may occur as a result of subcutaneous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutaneous injections of copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy occurs in HIV-associated lipodystrophy, one cause of which is an adverse drug reaction that is associated with some antiretroviral medications.

Health references

ICD-10
E88.10 — Lipodystrophy, unspecified
Source: U.S. National Library of Medicine (ICD-10-CM · MedlinePlus). Not medical advice.

Clinical Trials

216 registered

via ClinicalTrials.gov

Wikidata facts

Instance of
disease
Subclass of
lipodystrophy
Sources (3)

via Wikidata · CC0

Available in 8 languages

via Wikidata sitelinks · CC0